Drugs / beta interferon

Trials 1

201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03535298 Jan 2019 → Jul 2027 expected relapsing-remitting multiple sclerosis The Cleveland Clinic Active not recruiting No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as beta interferon “Betaseron (beta interferon)” NCT03535298 ↗
Known as Avonex (beta interferon) “Avonex (beta interferon)” NCT03535298 ↗
Known as Betaseron (beta interferon) “Betaseron (beta interferon)” NCT03535298 ↗
Known as Extavia (beta interferon) “Extavia (beta interferon)” NCT03535298 ↗
Known as Plegridy (beta interferon) “Plegridy (beta interferon)” NCT03535298 ↗
Known as Rebif (beta interferon) “Rebif (beta interferon)” NCT03535298 ↗